BANK VONTOBEL/CALL/BRISTOL-MYERS SQUIBB/65/0.1/20.09.24

BANK VONTOBEL/CALL/BRISTOL-MYERS SQUIBB/65/0.1/20.09.24 Stock

DE000VM8N550

Real-time Boerse Frankfurt Warrants 11:00:33 2024-06-03 EDT
0.003 ^EUR	+50.00%

3 months

-93.10%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BRISTOL-MYERS SQUIBB COMPANY

Chart BANK VONTOBEL/CALL/BRISTOL-MYERS SQUIBB/65/0.1/20.09.24

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Bristol Myers Squibb’s Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting	10:14am	BU
Bristol Myers: presents advances in lung cancer	08:58am	CF
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer	08:09am	BU
Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes	06-02	RE

More news

Quotes 5-day view

Date	Price	Change
24-06-03	0.003	+50.00%
24-05-31	0.002	0.00%
24-05-30	0.002	-33.33%
24-05-29	0.003	-25.00%
24-05-28	0.004	+100.00%

Real-time Boerse Frankfurt Warrants

Last update June 03, 2024 at 11:00 am

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	BRISTOL-MYERS SQUIBB COMPANY
Issuer	Vontobel
WKN	VM8N55
ISIN	DE000VM8N550
Date issued	2024-01-18
Strike	65 $
Maturity	2024-09-20 (109 Days)
Parity	10 : 1
Emission price	0.05 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.082 €
Lowest since issue	0.002 €
Spread	0.017 €
Spread %	85.00%

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Sector

More about the company